✦ LIBER ✦

Effects of the Vasopressin V2 Receptor Antagonist, Tolvaptan, on the Long-term Progression of Left Ventricular Dilatation in Patients with Heart Failure

✍ Scribed by James E. Udelson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Oral Tolvaptan on Left Ventri

✍ Cesare Orlandi; James Udelson; Christopher Zimmer; John Ouyang; Yoshitaka Yamamu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 17 KB

A Case of Severe Chronic Heart Failure S

✍ Yuna Yamagami; Hideyuki Kinoshita; Koichiro Kuwahara; Yoshihiro Kuwabara; Shinji 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Effects of V2-receptor antagonist tolvap

✍ Punniyakoti T. Veeraveedu; Kenichi Watanabe; Meilei Ma; Suresh S. Palaniyandi; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Effects of the AT1-receptor antagonist e

✍ George Suzuki; Takayuki Mishima; Elaine J Tanhehco; Victor G Sharov; Anastassia 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 382 KB

Effects of long-term oral treatment with

✍ Masayuki Takeuchi; Jong-Dae Lee; Hiromasa Shimizu; Takanori Ueda 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Acute hemodynamic effects of conivaptan,

✍ J.E. Udelson; W.B. Smith; G.H. Hendrix 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB